ACHV Insider Trading

Insider Ownership Percentage: 2.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Achieve Life Sciences Insider Trading History Chart

This chart shows the insider buying and selling history at Achieve Life Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$20k-$10k$0$10k$20kTotal Insider BuyingTotal Insider Selling

Achieve Life Sciences Share Price & Price History

Current Price: $2.65
Price Change: +0.30 (1.20%)
As of 03/13/2025 05:00 PM ET

This chart shows the closing price history over time for ACHV up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
AprMayJunJulAugSepOctNovDecJanFebMar$2.65Closing price on 03/13/25:

Achieve Life Sciences Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Achieve Life Sciences (NASDAQ:ACHV)

33.52% of Achieve Life Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ACHV by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$1.58Mbought$1.32MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$5M$0$5MTotal InflowsTotal Outflows
Achieve Life Sciences logo
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.
Read More on Achieve Life Sciences

Today's Range

Now: $2.65
Low: $2.59
High: $2.74

50 Day Range

MA: $3.20
Low: $2.65
High: $3.73

52 Week Range

Now: $2.65
Low: $2.59
High: $5.59

Volume

218,892 shs

Average Volume

256,400 shs

Market Capitalization

$91.13 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.67

Who are the company insiders with the largest holdings of Achieve Life Sciences?

Achieve Life Sciences' top insider investors include:
  1. John Bencich (CEO)
Learn More about top insider investors at Achieve Life Sciences.

Who are the major institutional investors of Achieve Life Sciences?

Achieve Life Sciences' top institutional shareholders include:
  1. Franklin Resources Inc. — 11.20%
  2. Geode Capital Management LLC — 2.20%
  3. Alyeska Investment Group L.P. — 1.22%
  4. Northern Trust Corp — 1.21%
  5. LPL Financial LLC — 0.57%
  6. Raymond James Financial Inc. — 0.46%
Learn More about top institutional investors of Achieve Life Sciences stock.

Which institutional investors are selling Achieve Life Sciences stock?

Within the last quarter, ACHV stock was sold by these institutional investors:
  1. Shay Capital LLC
  2. Alyeska Investment Group L.P.
  3. Franklin Resources Inc.
  4. Citadel Advisors LLC

Which institutional investors are buying Achieve Life Sciences stock?

During the last quarter, ACHV stock was bought by institutional investors including:
  1. Raymond James Financial Inc.
  2. Raymond James Financial Inc.
  3. Dumac Inc.
  4. JPMorgan Chase & Co.
  5. Northern Trust Corp
  6. Renaissance Technologies LLC
  7. Squarepoint Ops LLC
  8. Intech Investment Management LLC